CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 60 enrolled
Drug / intervention
Oculus Go Virtual Reality Gogglesdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05042999
NCT05042999N/ACompleted

The Use of Virtual Reality During Breast Ultrasound-Guided Biopsy Procedures

Prisma Health-Upstate·interventional·Posted Sep 13, 2021·Updated Apr 27, 2023

In Brief

A clinical study evaluating Oculus Go Virtual Reality Goggles for Breast Neoplasm Female. Completed, enrolled 60 participants across 1 site.

Detailed Summary

To determine if a virtual reality simulation will reduce pain and anxiety in patients undergoing an ultrasound guided breast biopsy procedure.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
CollaboratorsClemson University

Timeline

N/ACompletedFinished
20222023202420252026
First PostedSep 13, 2021
Enrollment StartSep 15, 2021
Primary CompletionJan 7, 2022
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 4.8 years ago

Interventions

Oculus Go Virtual Reality Gogglesdevice

Oculus Go is a standalone portable Virtual Reality device that enables the user to immerse in different virtual environments. Non pharmacological technique to reduce pain and anxiety during a procedure.